The philosophy that general manager’s were supposed to take when dealing with alleged PED users was to buy low. I understand the philosophy, but do not necessarily condone it. Anyway, signing a player for 3 years/$36 million isn’t exactly buying low. And if purchasing human growth hormone to enhance one’s performance isn’t enough of a negative, how about adding in the the fact that the player in reference is a hothead that cannot be good for a clubhouse, tends to overreact, and seems to look for trouble. And to top if off, he was acquired by a team that will almost certainly finish no better than fourth place in their own division, and isn’t exactly a large market team, to add one more slice of pie.
I see absolutely nothing positive about the signing of Jose Guillen. Make a splash by signing Andruw Jones if you are going to throw this extravagant money at Jose Guillen. I have heard that they are in the running to sign Jones anyway, but sign Jones and invest the other $12 million into a pitcher, or a few risky pitchers, or three $4 million players. I don’t know, but signing Jose Guillen just does not make any sense for a team that is in a rebuilding phase. And if Jose Guillen is supposed to be some kind of mentor in the clubhouse, then the young stars are in trouble.